Skip to content

Prospective Observational Lymphoedema Intensive Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01864044
Acronym
POLIT
Enrollment
306
Registered
2013-05-29
Start date
2009-09-30
Completion date
2012-12-31
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoedema

Brief summary

The aim of this observational study was to describe usual practices in lymphedema management in France. It was the opportunity to assess the effects of these practices on lymphedema volume in a large number of patients, to identify predictive factors of response, and to assess the safety of this therapy.

Detailed description

Lymphoedema is commonly treated according a strategy called Complex Decongestive Therapy (CDT). This CDT is usually composed of 2 different treatment phases. The first phase is an acute phase which aim is to reduce affected limb volume. The second phase is a maintenance phase which aim is to maintain as long as possible the volume reduction acheived during the first phase. These 2 phases required multi modal parameters such as bandages, lymphatic drainages, physical exercises...and can be managed very differently from one site to another.

Interventions

None listed

Sponsors

Thuasne
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* consecutive adult patients * hospitalized with a clinical diagnosis of unilateral stage II-III upper or lower limb lymphoedema of any etiology * indication for intensive decongestive therapy (IDT)

Exclusion criteria

* bilateral lymphedema, * lymphedema of both upper and lower limbs, * intensive decongestive therapy in the previous 6 months, * cancer recurrence, * systolic pressure index \< 0.5

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in affected limb volumeAt the end of 1st phase of Complex Decongestive Therapy and 6 months laterAccording to the site, the first phase can lasts 1, 2 or 3 weeks.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026